The NanoNeuroOmics project aims to bridge the gap between brain pathophysiology and molecular changes in the blood, focusing on two of the most challenging central nervous system disorders: Alzheimer’s disease (AD) and Glioblastoma (GBM).
Category: Research
Pioneering bedside genetic test for stroke to undergo further clinical evaluation
An innovative bedside genetic test being implemented in Manchester could dramatically improve outcomes for thousands of people in the UK affected by stroke each year. The test can tell healthcare professionals in approximately one hour if stroke patients will be more likely to benefit from clopidogrel, the current first-line treatment to prevent recurrence.
New trial of an anti-inflammatory antibiotic for pneumonia in people with a stroke
An antibiotic with anti-inflammatory properties will be trialed in 45 stroke units across the UK starting in early 2025. The trial, led by Professor Craig Smith will determine whether this additional treatment will improve clinical and health economic outcomes.
Imaging test to detect and monitor inflammation in brain tumours takes a step forward
Work on an imaging test to detect and monitor inflammation in brain tumours will take a step forward thanks to two new grants. Researchers within our brain imaging theme are developing a clinically applicable imaging test that could be used in all magnetic resonance imaging (MRI) scanners to help predict tumour growth and guide treatment.
First in vivo evidence of increased TSPO expression and inflammation in brains of patients with growing sporadic vestibular schwannomas
Scientists from our brain tumour theme along with colleagues from the Manchester Centre for Clinical Neurosciences, part of Northern Care Alliance NHS Foundation Trust have published a paper in Neuro-Oncology Advances. It is the first in vivo evidence of increased TSPO expression and inflammation within the brains of patients with growing sporadic vestibular schwannomas.
Major funding for heart and stroke research
Manchester is one of nine leading universities which will benefit from a record £35 million funding injection from the British Heart Foundation (BHF) to help strengthen world-leading cardiovascular disease research in the UK. The funding comes from the highly competitive Research Excellence Awards funding scheme.
Study sheds new light on devastating brain tumour
A team of researchers from The University of Manchester and the Geoffrey Jefferson Brain Research Centre have made an exciting discovery. This important research has been published in the prestigious journal Science Advances and could pave the way for new treatments in the future.
Helping prevent haemorrhagic stroke with The Natalie Kate Moss Trust
The Natalie Kate Moss Trust (NKMT) was set up in 2012 by the Moss family, following the sudden death of Natalie at the age of 26 after an unexpected brain haemorrhage.Focusing on turning this tragedy into something positive, their mission is to empower more people to...
brainHealth Manchester joins the £4.5m Blood Biomarker Challenge to Accelerate Alzheimer’s Research
Dementia theme lead Dr Ross Dunne will be overseeing the research team at the Dementia Research Centre and the brainHealth Manchester clinic in the Dementias Platform UK (DPUK) blood biomarker challenge, a project which aims to bring cutting-edge blood tests for diagnosing dementia within the NHS.
Podcast: Understanding NF2
NF2-Related Schwannomatosis is a rare genetic condition affecting 1 in 33,000. Despite its impact, it remains lesser known. Our latest podcast episode shines a light on NF2, making the complex understandable.
Address
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Connect with us
Recent Comments